Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene

Arthritis and Rheumatism

Volumn 50, Issue 12, 2004, Pages 4045-4050

  Aróstegui, Juan I ^a   Aldea, Anna ^a   Modesto, Consuelo ^b   Rua, Maria Jesús ^c   Argüelles, Federico ^d   González Enseñat, Maria Antonia ^e   Ramos, Eduardo ^f   Rius, Josefa ^a   Plaza, Susana ^a   Vives, Jordi ^a   Yagüe, Jordi ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL DE CRUCES   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^e HOSPITAL SANT JOAN DE DÉU   (Spain)

^f HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; CIAS1 GENE; CINCA SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRYOPYRIN ASSOCIATED PERIODIC SYNDROME; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; FEMALE; FEVER; GENE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC HETEROGENEITY; HUMAN; INFLAMMATORY DISEASE; LABORATORY TEST; MALE; MISSENSE MUTATION; MUCKLE WELLS SYNDROME; NALP3 GENE; PHENOTYPIC VARIATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYPAF1 GENE; QUESTIONNAIRE; RASH; RECURRENT DISEASE; SPAIN; TREATMENT OUTCOME; URTICARIA;

AUTOIMMUNE DISEASES; CARRIER PROTEINS; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; FEVER; GENETIC HETEROGENEITY; HUMANS; MALE; MUTATION, MISSENSE; PEDIGREE; RECURRENCE; SPAIN; SYNDROME; URTICARIA;

EID: 10444241090     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20633     Document Type: Article

References (15)

1. Grateau G. Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology (Oxford) 2004;43:410-5.
2. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Koloder RD. Mutations of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nature Genet 2001;29:301-5.
3. Dode C, Le Du N, Cuisset L, Letourneur F, Berthelot JM, Vaudour G, et al. New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am J Hum Genet 2002;70:1498-506.
4. Aganna E, Martinon F, Hawkins PN, Ross JB, Swan DC, Booth DR, et al. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 2002;46:2445-52.
5. Feldmann J, Prieur AM, Quartier P, Berquin P, Certain S, Cortis E, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002;71:198-203.
6. Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, Hofmann SR, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 2002;46:3340-8.
7. Prieur AM, Griscelli C, Lampert F, Truckenbrodt H, Guggenheim MA, Lovell DJ, et al. A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome: a specific entity analysed in 30 patients. Scand J Rheumatol 1987;66:57-68.
8. Granel B, Philip N, Serratrice J, Ene N, Grateau G, Dode C, et al. CIAS1 mutation in a patient with overlap between Muckle-Wells and chronic infantile neurological cutaneous and articular syndromes. Dermatology 2003;206:257-9.
9. Houten SM, Frenkel J, Waterham HR. Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation. Cell Mol Life Sci 2003;60:1118-34.
10. Manji GA, Wang L, Geddes BJ, Brown M, Merriam S, Al-Garawi A, et al. PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-κB. J Biol Chem 2002;277:11570-5.
11. Rosen-Wolff A, Quietzsch J, Schroder H, Lehmann R, Gahr M, Roesler J. Two German CINCA (NOMID) patients with different clinical severity and response to anti-inflammatory treatment. Eur J Haematol 2003;71:215-9.
12. Neven B, Callebaut I, Prieur AM, Feldmann J, Bodemer C, Lepore L, et al. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 2004;103:2809-15.
13. Federico G, Rigante D, Pugliese AL, Ranno O, Catania S, Stabile A. Etanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndrome. Scand J Rheumatol 2003;32:312-4.
14. Hawkins PN, Lachmann HJ, McDermott MF. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med 2003;348:2583-4.
15. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004;50:607-12.